Abstract
<P>Landmark studies identifying the unique susceptibility of the child’s developing brain to neurocognitive and neurobehavioral insults from lead have inspired a wealth of subsequent advances in our understanding of lead toxicity, exposure sources, screening approaches, treatment efficacy, and prevention strategies. However, ongoing data gaps are the source of healthy scientific debate regarding interpretation and clinical application of the current evidence base. This provides challenges to public health and medical practitioners striving for best evidence approaches to community and patient health.</P> <H4>ABOUT THE AUTHOR</H4> <P>Catherine Karr, MD, PhD, MS, is Assistant Professor, Department of Pediatrics, and Adjunct, Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA.</P> <P>Address correspondence to: Occupational and Environmental Medicine Program, Box 359739, 325 9th Ave., Seattle, WA 98104; fax 206-744-9935; or e-mail <a href="mailto:ckarr@u.washington.edu">ckarr@u.washington.edu</a>.</P> <P>Dr. Karr has disclosed no relevant financial relationships.</P> <H4>EDUCATIONAL OBJECTIVES</H4> <OL> <LI>Recognize the routes, sources, and patterns of lead exposure in children.</LI> <LI>Discuss the current guidelines regarding screening children for lead exposure, delineating their strengths and limitations.</LI> <LI>Review primary prevention strategies to reduce exposure to lead.</LI> </OL>
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
